PATENTS LICENSED FROM VEILED THERAPEUTICS, LLC

 

 

US 

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Prov. Appl. No. 61/877,521-Filed September 13, 2013

Australia

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 2014318471

Canada

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 2,922,002

China

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 201480062013X

Filed May 12, 2016

Europe

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 14780682.2

India

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 201647012079

Japan

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 2016-542842

Filed March 11, 2016

Korea

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 2016-7009662

 

Mexico

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. MX/a/2016/003265

 

New Zealand

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 717103

 

PCT

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

App. No. PCT/US2014/055539

 

Singapore

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 11201601311V

 

US

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Patent No. 9,468,603

 

US Continuation 1

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Appl. No. 15910913

Filed March 2, 2018

US

Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation

Granted Dec. 1, 2017

 

Australia

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 2012275953

 

Canada

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 2,836,914

 

China

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. ZL 2012800280815

 

Europe

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Appl. No. 12804651.3

 

India

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Appl. No. 10374/CHENP/2013

 

Japan

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 5621071

 

S. Korea

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 1444693

 

Mexico

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 337464

 

New Zealand

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 618596

 

Singapore

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 195018

 

Vietnam

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 16328

 

Vietnam (Divisional)

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Appl. No. 1-2014-01570

Patent No. 17042

 

US

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 8,440,714

US Continuation 1

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 8,716,328

US Continuation 2

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 9,339,555

US Continuation 3

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Patent No. 9,889,201

US Continuation 4

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

Appl. No. 15/675,399

 

Contact:

James D. McChesney, Ph.D.

147 County Road 245

Etta, MS  38627

Email: info@cloakedtherapeutics.com

 

 

All Rights Reserved | ©2018 CLOAKED THERAPEUTICS, LLC | Powered by Wix.com